A Study of Cemiplimab and Fianlimab in People With Nasopharyngeal Carcinoma

Clinical trial NCT07650266 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07650266
Sponsor: Memorial Sloan Kettering Cancer Center
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma Nasopharyngeal Cancer Nasopharynx Carcinoma Nasopharynx Cancer

Start date: 2026-09-01
Primary completion: 2030-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.